Published On: Mon, Mar 20th, 2017

Eli Lilly and Company reiterated as Neutral By UBS Securities

In an analyst rating update on Monday shares of Eli Lilly and Company (NYSE:LLY) had their rating reiterated by analysts at UBS Securities.

The broker said it has now set a ‘Neutral’ rating on shares of Eli Lilly and Company with a price target of 85. The price target according to the broker shows a possible increase of 1.05% from the current stock price of 84.12.


Over the last twelve months Eli Lilly and Company’s share price has increased from 0.00 to 84.12, changing by 0%.

The companies 50 day moving average is 80.89 and its 200 day moving average is 77.08. The 52 week high Eli Lilly and Company’s shares have peaked at is 86.14 whilst the 52 week low for the company’s shares is 64.18.

Eli Lilly and Company has 1,050,875,000 shares which are currently outstanding with a price of 84.12 calculating Eli Lilly and Company’s market capitalisation to 88.40B USD .

Parse error: syntax error, unexpected ‘=’, expecting ‘)’ in /home/newsden/public_html/wp-content/plugins/insert-php/insert_php.php(48) : eval()’d code on line 1